|
Sign In to gain access to subscriptions and/or personal tools.
|
Interleukin-6 (IL-6): A Possible Neuromodulator Induced by Neuronal Activity
Eric Jüttler
Victoria Tarabin
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Markus Schwaninger
Department of Neurology, University of Heidelberg, Heidelberg, Germany;Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany; markus.schwaninger{at}med.uniheidelberg.de
IL-6 and its receptor(s) are found in the CNS in health and disease. Cellular sources are glial cells and neurons. Glial production of IL-6 has intensively been studied, but comparatively little is known about the induction of IL-6 in neurons. Emerging evidence suggests that IL-6 possesses neurotrophic properties. Recent data show that neuronal IL-6 expression is induced by excitatory amino acids or membrane depolarization. This implicates that IL-6 is produced not only under pathological conditions but may play a critical role as a physiological neuromodulator that is induced by neuronal activity and regulates brain functions. In the following article, the authors review the current data on IL-6 expression in neurons, with special reference to the induction of IL-6 by neuronal activity. They discuss its direct and indirect effects as a neuromodulator and speculate about the possible function of IL-6 as a physiological regulatory molecule and as a neuroprotective agent in brain pathology.
Key Words: Interleukin-6 Membrane depolarization Cerebral ischemia Fever Depression Neuroprotection
The Neuroscientist, Vol. 8, No. 3,
268-275 (2002)
DOI: 10.1177/1073858402008003012

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Benedict, J. Scheller, S. Rose-John, J. Born, and L. Marshall
Enhancing influence of intranasal interleukin-6 on slow-wave activity and memory consolidation during sleep
FASEB J,
October 1, 2009;
23(10):
3629 - 3636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. K. de Jong, J. Vinet, V. S. Stanulovic, M. Meijer, E. Wesseling, K. Sjollema, H. W. G. M. Boddeke, and K. Biber
Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles
FASEB J,
December 1, 2008;
22(12):
4136 - 4145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pizzi, L. Manzoli, S. Mancini, and G. M. Costa
Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function
Eur. Heart J.,
May 1, 2008;
29(9):
1110 - 1117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Fleming and G. M. Harrington
What Is the Relationship Between Myocardial Perfusion Imaging and Coronary Artery Disease Risk Factors and Markers of Inflammation?
Angiology,
March 1, 2008;
59(1):
16 - 25.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Ng and D. E. Griffin
Acid Sphingomyelinase Deficiency Increases Susceptibility to Fatal Alphavirus Encephalomyelitis
J. Virol.,
November 15, 2006;
80(22):
10989 - 10999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sajadieh, O. W. Nielsen, V. Rasmussen, H. O. Hein, S. Abedini, and J. F. Hansen
Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease
Eur. Heart J.,
March 1, 2004;
25(5):
363 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|